Equifax's strong recent execution underpins the 83.5% market-implied probability of beating Q3 2026 consensus estimates, with the company reporting 11% revenue growth to $1.70 billion and adjusted EPS of $2.25 in Q2—exceeding analyst targets by 1.8%. Momentum stems from a 16% new-product Vitality Index driven by AI-enabled offerings and proprietary data, alongside 17% U.S. Information Services growth and international margin expansion. Traders price in continued outperformance ahead of the October 20 release, supported by management's raised AI cost-savings target and free-cash-flow guidance exceeding $1 billion for 2026. Key swing factors include mortgage revenue trends and any revisions to the $1.68–1.71 billion revenue range.